Published: August 2020 | Report Code: LS12068 | Available Format: PDF | Pages: 399
The medical gloves market revenue stood at $6,633.4 million in 2019, and it is projected to advance at a CAGR of 10.8% between 2020 and 2030. The growth can be attributed to the increasing risk of contagious diseases, rising elderly population, soaring healthcare expenditure, growing prevalence of chronic diseases, and growing volume of surgeries.
The COVID-19 pandemic has had a positive impact on the medical gloves industry, as it has caused a sudden surge in the demand for medical supplies. The healthcare industry is generating a huge demand for personal protective equipment (PPE), such as medical gloves, to protect patients and frontline health workers from spreading the virus during medical examinations and treatment. Moreover, the expanding pool of patients has resulted in a significant rise in the number of suppliers of these products. During the pandemic, companies such as Foxconn Technology Group and BYD Co. Ltd. have started manufacturing PPE items to fill the demand–supply gap and offer the requisite support to the healthcare system in these testing times.
In 2019, the nitrile category of the raw material segment accounted for the largest share in the medical gloves market due to the non-allergic properties of nitrile.
The examination category, within the application segment, generated the higher revenue in 2019, and it is expected to witness the faster growth in the coming years. This would be due to the increasing number of examination procedures, which is already higher than the number of surgical procedures.
The non-sterile category held the larger share in 2019, and it is projected to continue its domination on the market for medical gloves, under segmentation by sterility. This is due to the surging usage of non-sterile gloves for medical examinations. Whereas, the sterile category is expected to register the faster growth between 2020 and 2030 due to the soaring cases of COVID-19 and easy availability of sterile gloves in a wide range of sizes.
The non-powdered category, within the type segment, will observe the faster growth in the coming years owing to the non-allergic nature of these gloves.
The direct category, under the distribution channel segment, held the larger share in the medical gloves market in 2019, and it is expected to maintain its dominance in the future. Healthcare facilities prefer buying medical gloves from the manufacturers directly, instead of procuring them from indirect channels, as the end users require these items in large quantities. Direct distribution enables manufacturers to deliver their products in a short duration, thereby helping build long-term relationships with customers and avoid sharing the profits with a third-party distributor.
Hospitals, clinics, and diagnostic centers are expected to be the faster-growing end user category in the near future. Some of the key factors pushing this category’s growth include the escalating use of medical gloves, booming rate of patient hospitalization, soaring number of examinations and surgical procedures, and burgeoning cases of chronic disorders.
The strong presence of key players, extensive requirement for medical gloves in healthcare units, and high prevalence of COVID-19 will lead to the dominance of North America on the market in the coming years. The U.S. Department of Health and Human Services statistics reveal that 1 in 13 people in the country suffered from asthma in 2019. Moreover, the Office of Disease Prevention and Health Promotion states that the U.S. recorded 14.8 million new cases of chronic obstructive pulmonary disease (COPD) among adults in 2018.
This is propelling the medical gloves market because people suffering from such chronic respiratory disorders are more prone to contracting COVID-19. Thus, due to the leading COVID-19 case count, in which the high prevalence of other respiratory disorders is playing an important role, the demand for medical supplies, including gloves, is rising in the region.
The increasing prevalence of COVID-19, rising geriatric population, and mounting number of diagnostic examination and surgical procedures will aid the APAC region in demonstrating the fastest growth in the demand for medical gloves.
According to the Organization for Economic Co-operation and Development (OECD), the number of stem cell transplants in Japan increased from 5,032 in 2010 to 5,609 in 2015. Likewise, Australia recorded 37,600 transluminal coronary angioplasties in 2010 and 45,517 in 2017. Thus, the accelerating volume of surgeries and improving healthcare infrastructure will add to the market growth.
Customers around the world are showing preference for non-powdered medical gloves over powdered ones because of the non-allergic properties of the former. This trend in the medical gloves market is due to the starch present in powered gloves, which offers better hand movements and prevents the gloves from sticking to each other during packaging. However, the starch in these items can lead to severe allergic reactions while performing surgeries. Moreover, the easy availability of non-powdered gloves at a reasonable cost is boosting their global demand.
Recent outbreaks of SARS CoV-2 (COVID-19), Middle East respiratory syndrome (MERS), Ebola, severe acute respiratory syndrome (SARS), and Zika have made significant contributions to the growth of the market for medical gloves. Presently, medical authorities are taking extensive measures to contain the spread of coronavirus, as it is transmitted via direct contact and nasal droplets. Protective medical items, such as examination and surgical gloves, are designed to prevent infections by offering a barrier between the potentially pathogenic environment and the user.
According to the World Health Organization (WHO), cases of chronic diseases will increase by 57% by the end of 2020. Developing countries will witness most of them because of the consistent population growth. The growing incidence of chronic illnesses will result in a high volume of surgeries, thereby driving the medical gloves market advance. For instance, Mexico recorded an increase in the number of coronary artery bypass graft surgeries from 4,900 in 2015 to 5,125 in 2016. Similarly, the number in France grew from 19,242 in 2015 to 19,310 in 2016. Thus, the surging number of surgical procedures will generate a high demand for medical gloves worldwide.
|Base Year (2019) Market Size||$6,633.4 Million|
|Forecast Period CAGR||10.8%|
|Report Coverage||Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies’ Strategic Developments, Product Benchmarking, Company Profiling|
|Market Size by Segments||Raw Material, Application, Type, Sterility, Distribution Channel, End User, Geography|
|Market Size of Geographies||U.S., Canada, Germany, France, U.K., Italy, Spain, Netherlands, Switzerland, Belgium, Sweden, Austria, Denmark, Japan, China, Australia, India, South Korea, Hong Kong, Philippines, Indonesia, Brazil, Mexico, Colombia, Argentina, Chile, Saudi Arabia, South Africa, U.A.E, Qatar, Israel|
|Secondary Sources and References (Partial List)||Malaysian Rubber Gloves Manufacturers Association (MARGMA), Centers for Disease Control and Prevention (CDC), Organisation for Economic Co-operation and Development (OECD), World Health Organization (WHO), United States Food and Drug Administration (USFDA), Centers for Medicare & Medicaid Services (CMS)|
The medical gloves market is fragmented in nature, with the presence of market players such as Top Glove Corporation Bhd, SUPERMAX Corporation Berhad, Halyard Health Inc., Hartalega Holdings Berhad, Kossan Rubber Industries Bhd, Cardinal Health Inc., Paul Hartmann AG, B. Braun Melsungen AG, Medline Industries Inc., and Kimberly-Clark Corporation.
In recent years, players in the medical gloves industry have engaged in strategic developments, such as mergers & acquisitions and product launches, in order to stay ahead of their competitors. For instance:
The medical gloves market report offers comprehensive market segmentation analysis along with market estimation for the period 2014–2030.
Based on Raw Material
Based on Application
Based on Sterility
Based on Type
Based on Distribution Channel
Based on End User
The medical gloves market is projected to reach $20,435.6 million by 2030, from $6,633.4 million in 2019, progressing with a CAGR of 10.8% during 2020–2030.
The surging risk of contagious diseases, increasing geriatric population, growing volume of surgeries, rising burden of chronic diseases, and rising healthcare spending are the key factors driving the medical gloves market across the world.
Based on the type of gloves, non-powdered medical gloves currently account for the larger market share, as they contain fewer chemicals and proteins.
Nitrile, as a raw material, is the most used for the production of medical gloves.
Get a bespoke market intelligence solution
Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws